Evidence map›Paper›PMID 9155573›Full record

Trial reportGut1997

Efficacy of primed infusions with high dose ranitidine and omeprazole to maintain high intragastric pH in patients with peptic ulcer bleeding: a prospective randomised controlled study.

J Labenz, U Peitz, C Leusing, B Tillenburg, A L Blum, G Börsch

Open access · bronzeAbstract readClinical TrialComparative StudyRandomized Controlled Trial
In one paragraph

Trial report in Gut, 1997. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it, 130 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Ulcers: adjuvant PPIs to prevent major ulcer bleeds.Nature reviews. Gastroenterology & hepatology · 2009
    Article
  11. Management of upper gastrointestinal bleeding.Current gastroenterology reports · 2008
    Review
  12. Review
  13. Pharmacologic treatment of peptic ulcer bleeding.Current treatment options in gastroenterology · 2007
    Article
  14. Some Observations on PPI Therapy for Bleeding Ulcer.Gastroenterology & hepatology · 2006
    Article
  15. Review
  16. Switching between intravenous and oral pantoprazole.Journal of clinical gastroenterology · 2001
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

J LabenzDepartment of Internal Medicine and Gastroenterology, Elisabeth Hospital, Essen, Germany.
U Peitz
C Leusing
B Tillenburg
A L Blum
G Börsch
Elisabeth-Krankenhaus Essen · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIn healthy subjects, continuous infusions of high dose ranitidine and omeprazole produce high intragastric pH values.

aimTo test the hypothesis that both drugs also maintain high intragastric pH values in patients with bleeding ulcers. PATIENTS AND

methodsIn two parallel studies, 20 patients with bleeding duodenal ulcers and 20 patients with bleeding gastric ulcers were randomly assigned to receive either ranitidine (0.25 mg/kg/hour after a bolus of 50 mg) or omeprazole (8 mg/hour after a bolus of 80 mg) for 24 hours. Intragastric pH was continuously recorded with a glass electrode placed 5 cm below the cardia.

resultsBoth drugs rapidly raised the intragastric pH above 6. During the second 12 hour period, however, the percentage of time spent below a pH of 6 was 0.15% with omeprazole and 20.1% with ranitidine (p = 0.0015) in patients with duodenal ulcer; in patients with gastric ulcer it was 0.1% with omeprazole and 46.1% with ranitidine (p = 0.002).

conclusionsPrimed infusions of omeprazole after a bolus produced consistently high intragastric pH values in patients with bleeding peptic ulcers, whereas primed infusions with ranitidine were less effective during the second half of a 24 hour treatment course. This loss of effectiveness may be due to tolerance.

Indexed as

Hydrogen-Ion ConcentrationAdultAgedAged, 80 and overAnti-Ulcer AgentsDuodenal UlcerFemaleHumansMaleMiddle AgedOmeprazolePeptic Ulcer HemorrhageProspective StudiesRanitidineRegression AnalysisStomach UlcerAnti-Ulcer AgentsOmeprazoleRanitidine

Identifiers

PMID9155573
PMCPMC1027005
OpenAlexW2158435835

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.